Literature DB >> 33556313

2021 Canadian Urological Association (CUA)-Canadian Uro Oncology Group (CUOG) guideline: Management of castration-resistant prostate cancer (CRPC).

Fred Saad1, Armen Aprikian2, Antonio Finelli3, Neil E Fleshner3, Martin Gleave4, Anil Kapoor5, Tamim Niazi6, Scott A North7, Frederic Pouliot8, Ricardo A Rendon9, Bobby Shayegan5, Srikala S Sridhar10, Alan So4, Nawaid Usmani11, Eric Vigneault12, Kim N Chi13.   

Abstract

Entities:  

Year:  2021        PMID: 33556313     DOI: 10.5489/cuaj.7074

Source DB:  PubMed          Journal:  Can Urol Assoc J        ISSN: 1911-6470            Impact factor:   1.862


× No keyword cloud information.
  6 in total

1.  UPDATE - Canadian Urological Association guideline on androgen deprivation therapy: Adverse events and management strategies.

Authors:  Andrea Kokorovic; Alan I So; Hosam Serag; Christopher French; Robert J Hamilton; Jason P Izard; Jasmir G Nayak; Frédéric Pouliot; Fred Saad; Bobby Shayegan; Armen Aprikian; Ricardo A Rendon
Journal:  Can Urol Assoc J       Date:  2022-08       Impact factor: 2.052

Review 2.  The Health Economics of Metastatic Hormone-Sensitive and Non-Metastatic Castration-Resistant Prostate Cancer-A Systematic Literature Review with Application to the Canadian Context.

Authors:  Ivan Yanev; Jessy Gatete; Armen G Aprikian; Jason Robert Guertin; Alice Dragomir
Journal:  Curr Oncol       Date:  2022-05-07       Impact factor: 3.109

Review 3.  Patients with Positive Lymph Nodes after Radical Prostatectomy and Pelvic Lymphadenectomy-Do We Know the Proper Way of Management?

Authors:  Bartosz Małkiewicz; Miłosz Knura; Małgorzata Łątkowska; Maximilian Kobylański; Krystian Nagi; Dawid Janczak; Joanna Chorbińska; Wojciech Krajewski; Jakub Karwacki; Tomasz Szydełko
Journal:  Cancers (Basel)       Date:  2022-05-08       Impact factor: 6.575

Review 4.  Recommendations on Weight Loss and Healthy Lifestyle in Prostate Cancer Clinical Guidelines: A Systematic Review.

Authors:  Mario Rivera-Izquierdo; Virginia Martínez-Ruiz; José Juan Jiménez-Moleón
Journal:  Int J Environ Res Public Health       Date:  2022-01-27       Impact factor: 3.390

5.  Real-world experience of abiraterone acetate plus prednisone in chemotherapy-naive patients with metastatic castration-resistant prostate cancer: long-term results of the prospective ABItude study.

Authors:  G Procopio; V E Chiuri; M Giordano; A R Alitto; R Maisano; R Bordonaro; S Cinieri; S Rossetti; S De Placido; M Airoldi; L Galli; D Gasparro; G M Ludovico; P F Guglielmini; C Carella; P Nova; M Aglietta; L Schips; P Beccaglia; A Sciarra; L Livi; D Santini
Journal:  ESMO Open       Date:  2022-04-08

6.  The Triple-Tracer strategy against Metastatic PrOstate cancer (3TMPO) study protocol.

Authors:  Frédéric Pouliot; Jean-Mathieu Beauregard; Fred Saad; Dominique Trudel; Patrick O Richard; Éric Turcotte; Étienne Rousseau; Stephan Probst; Wassim Kassouf; Maurice Anidjar; Félix Camirand Lemyre; Guillaume F Bouvet; Bertrand Neveu; Amélie Tétu; Brigitte Guérin
Journal:  BJU Int       Date:  2021-11-11       Impact factor: 5.969

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.